London's benchmark FTSE 100 index struggled for momentum in Friday morning trading, posting a marginal gain of 0.1% to 9,978.89 by 0825 GMT. This slight uptick recovered only a fraction of the previous session's steep 1.3% decline, as investors grappled with conflicting signals from corporate news, economic data, and persistent geopolitical tensions.
Domestic Headwinds Weigh on Sentiment
Fresh economic indicators from the United Kingdom painted a concerning picture of consumer resilience. Official data showed retail sales declined by 0.4% in February. While this contraction was less severe than the 0.7% drop forecast by economists, it represented a sharp reversal from January's performance, which had been the strongest monthly increase since May 2024. Separately, the GfK consumer confidence index fell to -21 for March, marking its lowest level in eleven months, since April 2025.
Analysts pointed to underlying strains. Neil Bellamy at GfK noted a discernible "ripple of fear" within the March survey numbers. Matt Jeffers, Accenture's UK and Ireland retail strategy lead, highlighted that rising fuel and input costs are creating significant hurdles for retailers as they head into the spring season, squeezing margins and potentially forcing difficult pricing decisions.
AstraZeneca Provides a Lone Bright Spot
Amid the broader market sluggishness, pharmaceutical giant AstraZeneca (AZN) emerged as a notable gainer. The company's shares advanced following the announcement that its drug tozorakimab successfully helped reduce flare-ups in patients with chronic obstructive pulmonary disease (COPD) across two pivotal late-stage trials. This positive clinical news provided a counterweight to broader market concerns.
The session prior had seen dramatic swings in other individual names. Shares of investment firm 3i Group plummeted 17.6% after its discount retail holding, Action, projected that its 2026 same-store sales growth would only match 2025 levels. In contrast, retailer Next advanced 4.2%, though its management struck a cautious tone. CEO Simon Wolfson told Reuters that any price increases in June or July would be capped at a maximum of 1% to 2%. He expressed a larger concern that a prolonged conflict could drive transport and energy costs higher, risking a more general surge in manufactured goods prices.
Oil and Central Bank Policy Loom Large
The commodity markets continued to exert a powerful influence. Brent crude oil held firm above $107 a barrel, trading at $107.97. This price level is more than 48% higher than its mark at the outbreak of major conflict on February 28. Analyst Priyanka Sachdeva at Phillip Nova observed that "the market is trading on war longevity, not just headlines," suggesting a repricing based on sustained supply risks.
This elevated oil price presents a dilemma for London's market. A further surge in crude would likely stoke inflation fears, push bond yields higher, and intensify consumer spending restraint, negatively impacting high street retailers and domestic-focused companies well before providing any lift to the energy sector.
Central bank policy added another layer of complexity. In Europe, money markets priced in a 71% chance of an interest rate hike by the European Central Bank in April. Across the Channel, a Reuters poll showed most economists still believe the Bank of England will hold its key rate at 3.75% for the remainder of the year, even as financial markets increasingly bet on further tightening.
Gabriella Willis at Santander CIB acknowledged that "the risk of hikes has increased" if the conflict persists, but maintained her base view of steady rates. This was echoed by other commentators; the BoE's Alan Taylor stated the hurdle for another hike remained "high," while Morgan Stanley's Bruna Skarica argued policymakers would need "a lot more evidence" before considering a move.
Broader Market Context
The cautious mood in London was reflected across the continent, with the pan-European STOXX 600 index edging 0.2% lower by 0816 GMT. Susannah Streeter, chief investment strategist at Wealth Club, had anticipated a "struggle in early trade" for the FTSE, citing Brent crude's approach toward $110 a barrel and the weak domestic consumer data as dual headwinds.
The market's path forward appears heavily contingent on geopolitical developments. Analysts suggest a shift in diplomacy could rapidly alter the landscape, potentially flipping the script to favor the FTSE 100's heavyweight defensive stocks. For now, investors remain sidelined, balancing a single significant corporate positive against a backdrop of economic softness and enduring macro uncertainty.
